A successful clonazepam treatment without tolerance in a patient with spontaneous oral dyskinesia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 7, 2001, Pages 1477-1480

  Fukasawa, T ^a   Takahashi, M ^a   Otani, K ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Clonazepam; GABA; Spontaneous oral dyskinesia; Tardive dyskinesia

Indexed keywords

CLONAZEPAM; SULPIRIDE; TIAPRIDE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERANCE; DYSKINESIA; FEMALE; HUMAN; MEDICAL ASSESSMENT; PHENOMENOLOGY; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

AGED; ANTICONVULSANTS; CLONAZEPAM; DRUG TOLERANCE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS;

EID: 0034752155     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00193-2     Document Type: Article

References (7)

1. Tardive dyskinesia: Pathophysiology and animal model
2. Tardive dyskinesia: Review of treatments past, present, and future
3. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
4. Clonazepam treatment of tardive dyskinesia: A practical GABAmimetic strategy
5. Prevalence of spontaneous oral dyskinesia in the elderly
6. The prevalence of tardive dyskinesia